SCHEDULE 13G - 11-10-94 - NORTH AMERICAN BIOLOGICALS INCORPORATED

Company

Vaxart, Inc.

Filed

November 8, 1994

Accession Number

0000315066-94-001751

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →